Fig. 2.
Glycolysis is upregulated in angiogenic compared with invasive tumors. (A) MRS of invasive and angiogenic tumors. * P < .005; Lac=Lactate; mI=myo Inositol; Cr=creatine; Ch=choline; NAA+NAAG=; Glu+Gln=glutamine and glutamate; Tau=taurine; NAA+NAAG=N-acetylaspartate + N-acetyl-aspartylglutamate (B) Metabolic mapping of LDH activity in angiogenic compared with invasive tumors. Asterisk indicates necrotic area. (C) Quantification of metabolic mapping. (D) Lactate levels of invasive (P8) and angiogenic (P8-EGFRDN) human GBM cells in 48h and 120h of normoxia and hypoxia. *P < .05; ***P < .001.

Glycolysis is upregulated in angiogenic compared with invasive tumors. (A) MRS of invasive and angiogenic tumors. * P < .005; Lac=Lactate; mI=myo Inositol; Cr=creatine; Ch=choline; NAA+NAAG=; Glu+Gln=glutamine and glutamate; Tau=taurine; NAA+NAAG=N-acetylaspartate + N-acetyl-aspartylglutamate (B) Metabolic mapping of LDH activity in angiogenic compared with invasive tumors. Asterisk indicates necrotic area. (C) Quantification of metabolic mapping. (D) Lactate levels of invasive (P8) and angiogenic (P8-EGFRDN) human GBM cells in 48h and 120h of normoxia and hypoxia. *P < .05; ***P < .001.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close